Exelixis Inc at Stifel Virtual Healthcare Conference Transcript
All right. Good afternoon, everyone. I'm Stephen Willey, one of the Senior Biotech Analysts here at the firm. Very glad to have with us here this afternoon to present from Exelixis, Chief Executive Officer; Michael Morrissey.
I think we're just going to have kind of an informal discussion. I believe there's a kind of -- there's a chat function for those who are listening, there's a question that you feel is pressing, feel free to enter that question into that function and we hope to get that asked in as best appropriate. Mike, I'm not sure if there's any opening statements that you'd like to make before we get into Q&A at all.
Yes. Let me just remind everybody that we'll be making forward-looking statements today. So please see our SEC filings for a description of the risks that we face in our business. I think people on the call probably know us pretty well. So let's just get into
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
